Asia Pacific Biosafety Cabinet Market Forecast to 2028 -Regional Analysis - by Products Handled (Biological Products and Toxic Products), Category (Work Trays, Side Panel Construction, and Accessories), Type (Class I Biosafety Cabinet, Class II Type A2 &

Asia Pacific Biosafety Cabinet Market Forecast to 2028-Regional Analysis- by Products Handled (Biological Products and Toxic Products), Category (Work Trays, Side Panel Construction, and Accessories), Type (Class I Biosafety Cabinet, Class II Type A2 & Class II Type B1, Class II Type B2 Biosafety Cabinet, Class II Biosafety Cabinet, Customized Cabinets, and Others), Application (Medical Health, Disease Prevention, Food Safety, Biological Pharmacy, Environment Monitoring, and Others), and End User (Academic Centers, Biotech & Pharmaceutical Companies, Microbiology Centers, Research & Development Centers, Hospitals & Clinics, Diagnostic Laboratories, and Others)

The Asia Pacific biosafety cabinet market is expected to grow from US$ 36.23 million in 2023 to US$ 57.42 million by 2028. It is estimated to grow at a CAGR of 9.6% from 2023 to 2028.

Increasing Adoption of Cell-Based and Regenerative Therapies is Fueling Asia Pacific Biosafety Cabinet Market

Regenerative medicine can replace or heal tissues and organs damaged by age, disease, or trauma, and helps treat congenital disabilities. Over the last quarter of a century, there has been an emergence of the tissue engineering industry, one that has now evolved into a broader area of regenerative medicine. Regenerative medicine is a rapidly growing interdisciplinary field that involves engineering sciences to develop clinical therapies intended for maintenance, repair, replacement, and enhancement of biological function. The cell line development is a crucial and invariable part of regenerative medicine that helps understand how to treat injuries and diseases from broken bones to neurodegenerative diseases. These developmental procedures and protocols majorly involve the use of class-I and class-II biosafety cabinets to obtain optimum results and avoid contamination of pure cell cultures. This also helps comply with the principles good manufacturing practices of cell- based products. The cell-based therapy is extensively used in the treatment of various diseases such as cancer and autoimmune disorders. Therefore, the production of cell-based therapy products has increased. Thus, rise in the adoption of regenerative medicines and cell-based therapies is expected to be a prevalent trend in the Asia Pacific biosafety cabinet market during the forecast period.

Asia Pacific Biosafety Cabinet Market Overview

The Asia Pacific biosafety cabinet market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. China dominated the market in 2023. The biosafety cabinet market in China has experienced tremendous growth owing to the increasing presence of biotechnology companies, growing research and development facilities, and rising investments by biopharmaceutical companies. Rising strategic initiatives such as partnerships and increasing focus on research and development activities by pharmaceutical and biotechnology companies have accelerated the market growth in this country. China’s biotech industry has accelerated recently as National Medical Products Administration (NPMA) regulations were revamped for the fast development; many investors are eagerly funding the companies. Developments by companies drive the biosafety cabinet market growth in China. In November 2022, Haier Biomedical held a ceremony to launch the first batch of new biological safety cabinets (Model HR700-IIA2 and HR900-IIA-D) to deliver to international customers. Product launches are estimated to offer opportunities for the Asia Pacific biosafety cabinet market during the forecast period.

Asia Pacific Biosafety Cabinet Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Biosafety Cabinet Market Segmentation

The Asia Pacific biosafety cabinet market is segmented into products handled, category, type, application, end user, and country.

Based on products handled, the Asia Pacific biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held a larger share of the Asia Pacific biosafety cabinet market in 2023.

Based on category, the Asia Pacific biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held the largest share of the Asia Pacific biosafety cabinet market in 2023.

Based on type, the Asia Pacific biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held the largest share of the Asia Pacific biosafety cabinet market in 2023.

Based on application, the Asia Pacific biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held the largest share of the Asia Pacific biosafety cabinet market in 2023.

Based on end user, the Asia Pacific biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held the largest share of the Asia Pacific biosafety cabinet market in 2023.

Based on country, the Asia Pacific biosafety cabinet market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China dominated the Asia Pacific biosafety cabinet market in 2023.

ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Heal Force Bio-Meditech Holdings Ltd, International Marketers for Scientific Equipment’s & Technologies (IMSET), Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc are the leading companies operating in the Asia Pacific biosafety cabinet market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific biosafety cabinet market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific biosafety cabinet market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the biosafety cabinet market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution